… However, the development of suitable mucosal vaccines is extremely challenging, due to …
designing new vaccine delivery platforms. For infectious diseases’ vaccines these molecules …

… The efficacy of such vaccines relies on the identification and/or engineering of vaccine …
delivery systems that improve vaccine delivery to the targeted anatomic sites and immune cells. …

… an adjuvant-loaded vaccine delivery system, leading to robust … Recently, we have developed
a novel vaccine delivery system … This system therefore has the ability to co-deliver multiple …

… ability to enhance the nasal delivery of peptide/protein drugs and vaccines compared to the
… hydrogel nanocomposites for drug/vaccine delivery through the intranasal administration. …

… Lipopeptides were tested as vaccine delivery systems and evaluated for their immunogenicity
against Group A Streptococcus. Their IN administration demonstrated that the appropriate …

… One of the current challenges in developing tumor vaccines lies in finding effective immune
adjuvants or vaccine delivery systems to assist tumor antigens to induce antitumor cellular …

… vaccine against COVID-19, delivered exclusively with NFIS. In this review, we discuss physical
delivery methods for DNA vaccines … As is discussed, prophylactic DNA vaccines delivered …

… -based delivery systems satisfy the five expectations of an effective vaccine delivery system
as … Therefore, chitosan and its derivatives should be considered in vaccine development …

… ; and (2) mucosal vaccine delivery systems that include lipid-based or polymer-based particles
[Citation42]. In addition, mucosal vaccine delivery systems can be classified into two main …

… (TB) vaccine is necessity. However, the development of new subunit vaccines is faced with
concerns … To overcome such problems, polymers-based vaccine delivery systems have been …